Tag: Breast cancer
Agendia scores a genomic test from ordinary tumour slides
Agendia presented clinical validation of a deep learning pipeline that infers MammaPrint risk categories from H&E whole-slide images at ESMO…
SimBioSys wins FDA clearance for an MRI-based breast cancer risk score
SimBioSys has secured 510(k) clearance from the FDA for TumorSight Risk, a prognostic tool that estimates breast cancer recurrence risk…
Ataraxis model splits high-risk breast cancers by relapse odds
An AI that reads routine tumor slides alongside clinical notes separated two groups of high-risk patients whose five-year outcomes diverged…